tiprankstipranks
SAGE Therapeutics (SAGE)
NASDAQ:SAGE

SAGE Therapeutics (SAGE) Ownership - Who Owns SAGE Therapeutics?

877 Followers

SAGE Therapeutics (SAGE) Ownership Overview

7.91%34.18%17.35%40.56%
17.35% Other Institutional Investors
40.56% Public Companies and
Individual Investors
The ownership structure of SAGE Therapeutics (SAGE) stock is a mix of institutional, retail and individual investors. Approximately 51.53% of the company’s stock is owned by Institutional Investors, 7.91% is owned by Insiders and 40.56% is owned by Public Companies and Individual Investors.
The ownership structure of SAGE Therapeutics (SAGE) stock is a mix of institutional, retail and individual investors. Approximately 51.53% of the company’s stock is owned by Institutional Investors, 7.91% is owned by Insiders and 40.56% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 11, 2023
xxxxxxxxxxxxx
$37260

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$1044661
Mar 31, 2024
xxxxxxxxxxxxx
$1964532
Mar 31, 2024
xxxxxxxxxxxxx
$5153500
Mar 31, 2024
xxxxxxxxxxxxx
$7631246

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,803,377Institution7.98%56,487,714
4,430,016Institution7.36%52,096,988
2,859,637Institution4.75%33,629,331
2,620,871Institution4.35%30,821,443
2,484,000Institution4.13%29,211,840
2,124,699Insider3.53%24,986,460
1,319,637Institution2.19%15,518,931
1,232,649Insider2.05%14,495,952
969,906Institution1.61%11,406,095
922,252Institution1.53%10,845,684

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,430,016Institution7.36%52,096,988
2,859,637Institution4.75%33,629,331
2,620,871Institution4.35%30,821,443
969,906Institution1.61%11,406,095
922,252Institution1.53%10,845,684
567,694Institution0.94%6,676,081
555,824Institution0.92%6,536,490
553,588Institution0.92%6,510,195
535,641Institution0.89%6,299,138
472,445Institution0.79%5,555,953

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,550,086Institution2.58%17,221,455
1,319,234Institution2.19%15,481,211
1,253,017Institution2.08%14,704,155
1,306,907Institution2.17%14,519,737
792,747Institution1.32%8,807,419
741,875Institution1.23%8,242,231
574,368Institution0.95%6,754,568
500,373Institution0.83%5,871,877
361,348Institution0.60%4,249,452
248,504Institution0.41%2,916,194

FAQ

Who Owns SAGE Therapeutics (SAGE)?
According to the latest TipRanks data, approximately 17.35% of the company's stock is held by institutional investors, 7.91% is held by insiders, and 40.56% is held by retail investors.
    What percentage of SAGE Therapeutics (SAGE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 17.35% of SAGE Therapeutics (SAGE) stock is held by institutional investors.
      What percentage of SAGE Therapeutics (SAGE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 40.56% of SAGE Therapeutics (SAGE) stock is held by retail investors.
        Who owns the most shares of SAGE Therapeutics (SAGE)?
        Vanguard owns the most shares of SAGE Therapeutics (SAGE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis